Mitophagy: an emerging therapeutic target in mitochondrial diseases
Biochemical Journal · 08.07.2026 · 483 (7) · 1193-1220
DOI: 10.1042/bcj20260161 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochemical Journal, online erschienen am 10.06.2026. Verfasst von Brígida R Pinho und 2 weiteren Autor:innen. Beteiligte Einrichtung: UCIBIO Applied Molecular Biosciences Unit, Mitochondria and Neurobiology Lab, Faculdade de Farmácia, Universidade do Porto, 4500-313 Porto, Portugal. Hauptthemen laut MEDLINE: Mitophagy, Mitochondrial Diseases, Mitochondria. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 211 Literaturangaben. Gefördert von: EC | European Regional Development Fund (ERDF), MEC | Fundação para a Ciência e a Tecnologia (FCT), Action Medical Research (AMR).
Abstract (Originalsprache)
Mitophagy is a crucial autophagic process that degrades dysfunctional or unnecessary mitochondria, thereby maintaining cellular homeostasis. Mitophagy occurs through both basal mitophagy and stress-induced pathways, highly regulated by a complex network of proteins. In mitochondrial diseases, which are genetic disorders lacking effective treatments, mitophagy is often defective or insufficient. This permits the accumulation of dysfunctional mitochondria that negatively impact cell homeostasis. While some experimental therapeutic strategies have enhanced mitophagy in mitochondrial disorders by targeting broadly acting signaling pathways, such as mTORC1 inhibition or AMPK activation, pharmacological approaches directly targeting the mitophagy process remain underexplored in these disorders. Given the growing understanding of mitophagy regulation, targeting key proteins involved in this process may offer novel therapeutic opportunities for mitochondrial diseases. Here, we explore the molecular mechanisms of mitophagy, examining distinct pathways and regulatory checkpoints that might present potential therapeutic targets. Additionally, we review recent studies evaluating the effects of mitophagy modulation in mitochondrial diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- UCIBIO Applied Molecular Biosciences Unit, Mitochondria and Neurobiology Lab, Faculdade de Farmácia, Universidade do Porto, 4500-313 Porto, Portugal.
- Associate Laboratory i4HB Institute for Health and Bioeconomy, Universidade do Porto, 4500-313 Porto, Portugal.
- Department of Cell and Developmental Biology, University College London, London WC1E 6BT, U.K.
ORCID-Profile: Brígida R Pinho, Michael R Duchen, Jorge M A Oliveira
Förderung
- EC | European Regional Development Fund (ERDF)
- MEC | Fundação para a Ciência e a Tecnologia (FCT)
- Action Medical Research (AMR)
Zitieren
APA
Pinho, B. R., Duchen, M. R., & Oliveira, J. M. A. (2026). Mitophagy: an emerging therapeutic target in mitochondrial diseases. Biochemical Journal, 483(7), 1193-1220. https://doi.org/10.1042/bcj20260161
Vancouver
Pinho BR, Duchen MR, Oliveira JMA. Mitophagy: an emerging therapeutic target in mitochondrial diseases. Biochemical Journal. 2026;483(7):1193-1220. doi:10.1042/bcj20260161
BibTeX
@article{Pinho2026,
author = {Pinho, Brígida R and Duchen, Michael R and Oliveira, Jorge M A},
title = {Mitophagy: an emerging therapeutic target in mitochondrial diseases},
journal = {Biochemical Journal},
year = {2026},
volume = {483},
number = {7},
pages = {1193--1220},
doi = {10.1042/bcj20260161}
}
EUVIMED